Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19195022

Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma

Author
CORREN, Jonathan1 ; KORENBLAT, Phillip E2 ; MILLER, Christopher J3 ; O'BRIEN, Christopher D3 ; MEZZANOTTE, William S3
[1] Allergy Research Foundation, Los Angeles, California, United States
[2] The Clinical Research Center, St. Louis, Missouri, United States
[3] AstraZeneca LP, Wilmington, Delaware, United States
Source

Clinical therapeutics. 2007, Vol 29, Num 5, pp 823-843, 21 p ; ref : 30 ref

ISSN
0149-2918
Scientific domain
Pharmacology drugs
Publisher
Excerpta Medica, Belle Mead, NJ
Publication country
United States
Document type
Article
Language
English
Author keyword
asthma budesonide/formoterol dry powder inhaler efficacy pressurized metered-dose inhaler tolerability
Keyword (fr)
Adolescent Adulte Antiasthmatique Antiinflammatoire Asthme Aérosol doseur Bronchodilatateur Budésonide Efficacité traitement Etude comparative Etude multicentrique Formotérol Placebo Poudre Randomisation Toxicité Agoniste Appareil respiratoire pathologie Bronche pathologie Bronchopneumopathie obstructive Corticostéroïde Homme Poumon pathologie Récepteur β2-adrénergique Stimulant β-adrénergique Système administration
Keyword (en)
Adolescent Adult Antiasthma agent Antiinflammatory agent Asthma Metered dose inhaler Bronchodilator Budesonide Treatment efficiency Comparative study Multicenter study Formoterol Placebo Powder Randomization Toxicity Agonist Respiratory disease Bronchus disease Obstructive pulmonary disease Corticosteroid Human Lung disease β2-Adrenergic receptor β-Adrenergic receptor agonist Delivery system
Keyword (es)
Adolescente Adulto Agente antiasma Antiinflamatorio Asma Aerosol dosificador Broncodilatador Budesónida Eficacia tratamiento Estudio comparativo Estudio multicéntrico Formoterol Placebo Polvo Aleatorización Toxicidad Agonista Aparato respiratorio patología Bronquio patología Broncopneumopatía obstructiva Corticoesteroide Hombre Pulmón patología Receptor β2-adrenérgico Estimulante β-adrenérgico Sistema administración
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B11 Pneumology / 002B11B Chronic obstructive pulmonary disease, asthma

Discipline
General pharmacology Pulmonology
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
19195022

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web